| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 10/07/2004 | WO2004084813A2 Chemical compounds |
| 10/07/2004 | WO2004084809A2 Neuroprotective macrocylic compounds and methods for their use |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198767 Salt of naphthyridine carboxylic acid derivative |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198764 Prodrugs of imidazopyridine derivatives |
| 10/07/2004 | US20040198756 Piperidien compound; bactericide |
| 10/07/2004 | US20040198755 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/07/2004 | US20040198724 Contacting a cell with a quinazolinones containing sulfur or its oxides in an amount sufficient to open the potassium channels for the treatment of central or peripheral nervous system disorders |
| 10/07/2004 | US20040198719 Antagonist of MCP-1 function, and compositions and methods of use thereof |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040198693 Purine-type compounds: A3 agonists |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | CA2518909A1 Heterocyclic compounds and methods of use |
| 10/07/2004 | CA2515605A1 Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463718A1 2-substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463563A1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1463495A2 Agents and methods for treatment of cancer |
| 10/06/2004 | EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1037892B1 Piperidine derivatives |
| 10/06/2004 | EP0970070B1 Phthalazines with angiogenesis inhibiting activity |
| 10/06/2004 | CN1535272A Nitrogen-containing bicyclic heterocycles |
| 10/06/2004 | CN1534023A Heterocyclic compound as dopamine-D3ligand |
| 10/06/2004 | CN1169809C BOC protective beta-tetrahydro carboline carboxylic acid and its nano-preparation, its RGD conjugate, their synthesis and medical application |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/06/2004 | CN1169527C Methods of modulating serine-threnoine protein kinase function with 5-azaquinoxaline-based compounds |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 10/05/2004 | US6800640 Antiserotonine agents; central nervous system disorders |
| 10/05/2004 | US6800638 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800625 For therapy of sexual dysfunction |
| 10/05/2004 | US6800624 Sulfonamide and sulfamide substituted imidazoquinolines |
| 10/05/2004 | US6800621 Imidazo[4,5-b]-pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum activity |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2244698C Derivatives of camptothecin for use in treating cancer |
| 09/30/2004 | WO2004083215A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083207A1 Naphthyridine derivatives as antibacterial agents |
| 09/30/2004 | WO2004083177A2 Linear chain substituted monocyclic and bicyclic derivatives as factor xa inhibitors |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004082698A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 09/30/2004 | WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004032854A3 Pharmaceutical compositions for treatment of parkinson's disease |
| 09/30/2004 | WO2003101949A3 Process for imidazo[4,5-c]pyridin-4-amines |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192721 Fungicidal properties of sampangine and its analogs to agriculturally important fungal plant pathogens |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192719 Peptide deformylase inhibitors |
| 09/30/2004 | US20040192718 Substituted pyrroline kinase inhibitors |
| 09/30/2004 | US20040192709 7-oxo-pyridopyrimidines (II) |
| 09/30/2004 | US20040192697 Pyrrolopyridine potassium channel openers |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
| 09/30/2004 | US20040192653 P38 inhibitors and methods of use thereof |
| 09/30/2004 | US20040191917 phase transfer agents; for production of optical sensors |
| 09/30/2004 | US20040191210 Compounds |
| 09/30/2004 | US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 09/30/2004 | US20040191184 Delivery of muscle relaxants through an inhalation route |
| 09/30/2004 | US20040191183 Delivery of antiemetics through an inhalation route |
| 09/30/2004 | US20040191182 Delivery of analgesics through an inhalation route |
| 09/30/2004 | US20040191181 Vaporization of diphenhydramine from solid for breathing administerig |
| 09/30/2004 | US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches |
| 09/30/2004 | US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support |
| 09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519220A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2518443A1 Naphthyridine derivatives as antibacterial agents |
| 09/30/2004 | CA2517755A1 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/29/2004 | EP1462452A1 Bicarbonate receptor compounds |
| 09/29/2004 | EP1462449A1 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha levels |
| 09/29/2004 | EP1461339A2 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/29/2004 | EP1461338A1 Improved process for the preparation of 3-(2-'4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl/ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido'1,2-a/pyrimidin-4-one |
| 09/29/2004 | EP1461337A1 Pyrido[2,1-a]isoquinoline derivatives as dpp-iv inhibitors |
| 09/29/2004 | EP1461040A1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461036A2 Bis hydrochloride monohydrate salt of rsv fusion inhibitor |
| 09/29/2004 | EP1461035A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |